Shanmuga Hospital Limited (BOM:544365)
India · Delayed Price · Currency is INR 37.00
-0.76 (-2.01%)
At close: Jun 17, 2026
Shanmuga Hospital Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 474.36 | 478.53 | 430.37 | 393.45 | 413.82 |
Other Revenue | 6.27 | 1.64 | 2.35 | - | 0.82 |
| 480.63 | 480.17 | 432.73 | 393.45 | 414.64 | |
Revenue Growth (YoY) | 0.10% | 10.96% | 9.98% | -5.11% | 992.91% |
Cost of Revenue | 223.27 | 254.92 | 222.2 | 208.82 | 189.51 |
Gross Profit | 257.36 | 225.25 | 210.53 | 184.63 | 225.13 |
Selling, General & Admin | - | 12.96 | 12.4 | 10.49 | 50.12 |
Other Operating Expenses | 168.28 | 128.27 | 109.82 | 101.13 | 83.79 |
Operating Expenses | 196.44 | 162.81 | 135.25 | 117.42 | 135.22 |
Operating Income | 60.92 | 62.44 | 75.28 | 67.21 | 89.9 |
Interest Expense | -4.22 | -5.59 | -5.2 | -2.68 | - |
Interest & Investment Income | - | 0.7 | 1.15 | 0.21 | 0.08 |
Other Non Operating Income (Expenses) | -0 | -0.68 | -0.88 | 1.17 | -0.33 |
EBT Excluding Unusual Items | 56.7 | 56.87 | 70.35 | 65.91 | 89.65 |
Other Unusual Items | - | - | -0.13 | - | - |
Pretax Income | 56.7 | 56.87 | 70.22 | 65.91 | 89.65 |
Income Tax Expense | 14.6 | 14.81 | 17.74 | 16.59 | 22.47 |
Net Income | 42.11 | 42.07 | 52.48 | 49.32 | 67.18 |
Net Income to Common | 42.11 | 42.07 | 52.48 | 49.32 | 67.18 |
Net Income Growth | 0.09% | -19.85% | 6.41% | -26.58% | 2255.01% |
Shares Outstanding (Basic) | 14 | 10 | 10 | 10 | 10 |
Shares Outstanding (Diluted) | 14 | 10 | 10 | 10 | 10 |
Shares Change (YoY) | 30.63% | 6.50% | 0.77% | - | 0.00% |
EPS (Basic) | 3.09 | 4.03 | 5.36 | 5.07 | 6.91 |
EPS (Diluted) | 3.09 | 4.03 | 5.36 | 5.07 | 6.91 |
EPS Growth | -23.33% | -24.79% | 5.59% | -26.56% | 2254.34% |
Free Cash Flow | -81.53 | -170.39 | -19.34 | -53.8 | 2.46 |
Free Cash Flow Per Share | -5.98 | -16.34 | -1.97 | -5.54 | 0.25 |
Gross Margin | 53.55% | 46.91% | 48.65% | 46.93% | 54.30% |
Operating Margin | 12.68% | 13.00% | 17.40% | 17.08% | 21.68% |
Profit Margin | 8.76% | 8.76% | 12.13% | 12.54% | 16.20% |
Free Cash Flow Margin | -16.96% | -35.49% | -4.47% | -13.67% | 0.59% |
EBITDA | 89.08 | 84.02 | 88.32 | 73 | 91.22 |
EBITDA Margin | 18.54% | 17.50% | 20.41% | 18.55% | 22.00% |
D&A For EBITDA | 28.17 | 21.58 | 13.04 | 5.79 | 1.32 |
EBIT | 60.92 | 62.44 | 75.28 | 67.21 | 89.9 |
EBIT Margin | 12.68% | 13.00% | 17.40% | 17.08% | 21.68% |
Effective Tax Rate | 25.74% | 26.04% | 25.26% | 25.17% | 25.06% |
Revenue as Reported | 480.63 | 480.87 | 433.88 | 394.96 | - |
Advertising Expenses | - | 6.82 | 4.94 | 3.04 | - |